Zoledronate
Peripheral Nerve Sheath Tumors
University of FloridaSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Peripheral Nerve Sheath Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Zirconium Zr 89-Dfo-Ys5 Robert Flavell, MD, PhD | Phase 1 | CC |
Same molecule, other indications
Zoledronate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →